Kong Rong Pan
Geschäftsführer bei PEIJIA MEDICAL LIMITED
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yi Zhang | M | 54 |
Peijia Medical Technology (Suzhou) Co. Ltd.
 Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 12 Jahre |
| Hong Ye | M | 51 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 12 Jahre |
| Ping Ye Zhang | F | 56 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 12 Jahre |
| Ji Feng Guan | M | 55 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 8 Jahre |
| Hong Peng Wang | F | 44 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 5 Jahre |
| Robert Ralph Parks | M | 79 | 4 Jahre | |
| Stephen Oesterle | M | 73 | 4 Jahre | |
| Zhi Yun Yu | M | 45 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 8 Jahre |
| Fei Chen | M | 44 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 5 Jahre |
| Hua Cheng Wei | M | 64 | 3 Jahre | |
| Wai Ming Yip | M | 59 | 4 Jahre | |
| Hing Ling Chau | F | 49 | 2 Jahre | |
| Bing Shang | M | 56 |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | 5 Jahre |
| Lieh Tsai | M | 43 | 5 Jahre | |
| Jian Fong Tan | M | 48 | - | |
| Chen Wang | F | 48 | - | |
| Xiao Li Shi | F | 38 | - | |
| Xiao Ping Zhong | F | 47 | - | |
| Jun Yang | M | 43 | 4 Jahre | |
| Xin Zhang | M | 50 | 3 Jahre | |
| Xiao Xiao Zhuang | F | 41 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Dian Fu Ma | M | 64 |
Beihang University
| 21 Jahre |
| Huan Rong Li | M | 61 |
Beihang University
| 7 Jahre |
| Zhuo Ping Hou | F | 46 |
Shanghai Microport Medical (Group) Co., Ltd.
 Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 11 Jahre |
| Chris Rasmussen | M | - |
The Curtis L. Carlson School of Management
| 7 Jahre |
| Guang Lei Jin | M | - |
Shanghai University of Technology
| 4 Jahre |
| Joe McConnell | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| George Gibson | M | 58 |
The Curtis L. Carlson School of Management
| 5 Jahre |
| Liang Song Yao | M | 60 |
Beihang University
| 4 Jahre |
| Zhong Qiu Yang | M | - |
Beihang University
| 4 Jahre |
| Steve L. Kavan | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| Richard Rodgers | M | 57 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Qing Sheng Zhu | M | 61 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| James Claussen | M | 51 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Dong Sheng Yang | M | 60 |
Beihang University
| 4 Jahre |
| Fan Sheng Bo | M | 71 |
Beihang University
| 4 Jahre |
| Mark Vaupel | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| Michael Rodger Buttshaw | M | 61 |
The Curtis L. Carlson School of Management
| 1 Jahre |
| Qing Jun Sun | M | 59 |
Beihang University
| 4 Jahre |
| Lian Sheng Pan | M | 60 |
Beihang University
| 4 Jahre |
| Qing Liu | F | 60 |
Beihang University
| 4 Jahre |
| Yue Hong Qian | M | 60 |
Beihang University
| 4 Jahre |
| Jason Hegrenes | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Xun Jiang | M | 69 |
Beihang University
| 4 Jahre |
| Jim Sorboro | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| Xuyang Xie | M | 48 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 3 Jahre |
| Jie Zhang | M | 59 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 8 Jahre |
| Gang Li | M | 61 |
Beihang University
| 4 Jahre |
| Lei Duan | M | 42 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 8 Jahre |
| Zhi Yong Xie | M | 48 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 13 Jahre |
| Tao Qin | M | 51 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 7 Jahre |
| Guo Ming Chen | M | 39 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 6 Jahre |
| Yu QifengY | M | 45 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 5 Jahre |
| Chao He | M | 40 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 1 Jahre |
| Jared Oasheim | M | 41 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Shan Hong Mao | M | 59 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Ming Xing Jia | M | 61 |
Beihang University
| 4 Jahre |
| Jie Yin | M | 49 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | 2 Jahre |
| Christian F. Lundsgaard | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Yan Sun | M | 60 |
Beihang University
| 4 Jahre |
| Yi Zhao | M | 70 |
Beihang University
| 4 Jahre |
| Dustin R. Benson | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Steve Denault | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| Rui Song Tan | M | 62 |
Beihang University
| 4 Jahre |
| Hong Li | M | 61 |
Beihang University
| 4 Jahre |
| Ru Guang Geng | M | 67 |
Beihang University
| 4 Jahre |
| Dian Qing Hao | M | 72 |
Beihang University
| 4 Jahre |
| Xiao Ping Liu | M | 69 |
Beihang University
| 1 Jahre |
| Avanish Vellanki | M | 49 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Josh Baltzell | M | 55 |
The Curtis L. Carlson School of Management
| 1 Jahre |
| Stacey M. Curme | F | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Todd S. Emerson | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Parag Agarwal | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Mike Stellmacher | M | 69 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Paul Jerome Jungquist | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Mark H. Book | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Bryce A. Doty | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| John M. Bernstein | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Jason Ballsrud | M | 50 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Yong Gang Ren | M | 59 |
Beihang University
| 4 Jahre |
| Fang Yong Li | M | 61 |
Beihang University
| 4 Jahre |
| Charles Kummeth | M | 63 |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Patrick Regan | M | - |
The Curtis L. Carlson School of Management
| 2 Jahre |
| Jia Jun Ning | M | 79 |
Beihang University
| 4 Jahre |
| Qi Gang Bian | M | 65 |
Beihang University
| 4 Jahre |
| Xiao Hua Zheng | F | 67 |
Beihang University
| 4 Jahre |
| Michael R. Boardman | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
| Zhen Fu Li | M | 59 |
Beihang University
| 4 Jahre |
| Zhi Guang Zheng | M | 68 |
Beihang University
| 4 Jahre |
| Ying Zhang | M | - |
Beihang University
| 4 Jahre |
| Eric Paul Glass | M | - |
The Curtis L. Carlson School of Management
| 1 Jahre |
| Feng Li | M | 62 |
Beihang University
| 4 Jahre |
| Hong Bin Sun | M | 48 |
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | - |
| Jia Lin Fu | M | 63 |
Beihang University
| 4 Jahre |
| Xiao Hua Qian | M | 61 |
Beihang University
| 4 Jahre |
| Philip J. Albert | M | 58 |
The Curtis L. Carlson School of Management
| 1 Jahre |
| Xi Hua Xia | M | 61 |
Beihang University
| 4 Jahre |
| Jun Zhu | M | 61 |
Beihang University
| 4 Jahre |
| Zhen Mu Wu | M | 78 |
Beihang University
| 1 Jahre |
| Chris Hasslinger | M | - |
The Curtis L. Carlson School of Management
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 46 | 46,00% |
| Vereinigte Staaten | 33 | 33,00% |
| Cayman Islands | 21 | 21,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Kong Rong Pan
- Persönliches Netzwerk
